The Fund seeks to generate income and achieve long term capital growth through active management of a diversified portfolio invested primarily in UK equities.
The UK stockmarket, as measured by the FTSE All Share Index fell by 13.2% in Sterling terms during September. The Fund underperformed its benchmark during the month. On a relative basis the largest contributor to performance was Rio Tinto. The Fund is underweight this stock. The Fund also benefited from its overweight position in Catlin Group and Imperial Tobacco. The Fund's holding in HBoS was the largest detractor to performance during the month.Although merger talks with LloydsTSB are well advanced, the company has been hit hard during the ongoing credit crisis and this has had a significant impact on its share price. Additional detractors to performance during the month included overweight holdings in Vedanta Resources and AstraZeneca.
Equity markets are likely to remain volatile until it becomes clear how the world economy will emerge from its current period of weakness.
Latest Price | 76.86p | IMA Sector | UK Equity Income |
---|---|---|---|
Currency | British Pound | Launch Date | 30/03/2007 |
Fund Size | n/a | Fund Manager | |
ISIN | GB0031615841 | Dividend | 0.00p |
Date | 20-Sep-2019 |
---|---|
NAV | 76.86p |
Currency | GBP |
Change | 0.93p |
% | 1.22% |
YTD change | 76.86p |
YTD % | n/a |
Fund Inception | 30/03/2007 |
---|---|
Fund Manager | n/a |
TER | 1.75 (31-Jan-2014) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 1.96 |
Sharpe ratio | 0.24 |
You are here: research